Results
341
Companies with a Future performance score of at least 3, ordered by Future performance score.
341 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
WAYS | SEK 15.72 | -8.8% | -46.4% | SEK 126.9m | SEK 36.50 | PS1x | E113.3% | 0% | Tech | ||
INIT | SEK 6.80 | -4.2% | -26.6% | SEK 382.5m | SEK 22.50 | PB15.8x | E31.7% | n/a | Pharmaceuticals & Biotech | ||
NEWBRY | SEK 3.52 | -2.2% | 8.6% | SEK 85.4m | SEK 8.00 | PS2.3x | E130.0% | n/a | Pharmaceuticals & Biotech | ||
ACE | SEK 3.00 | -11.5% | -16.4% | SEK 288.3m | SEK 8.25 | PB2.7x | E47.2% | n/a | Pharmaceuticals & Biotech | ||
ENRAD | SEK 10.00 | -2.9% | 100.0% | SEK 244.1m | SEK 8.90 | PE62.2x | E50.9% | n/a | Capital Goods | ||
TFBANK | SEK 370.00 | 1.6% | 124.2% | SEK 8.0b | SEK 405.00 | PB3.2x | E27.1% | n/a | Banks | ||
JOBS | SEK 21.20 | 1.0% | -24.3% | SEK 105.3m | SEK 39.00 | PE12.8x | E45.3% | 7.8% | Commercial Services | ||
ENGCON B | SEK 102.20 | -6.1% | 13.7% | SEK 15.5b | SEK 108.33 | PE89.6x | E42.1% | 0.9% | Capital Goods | ||
CAMX | SEK 563.50 | 2.4% | 8.2% | SEK 33.1b | SEK 745.00 | PE124.5x | E83.1% | n/a | Pharmaceuticals & Biotech | ||
YUBICO | SEK 241.00 | -7.7% | 106.7% | SEK 20.8b | SEK 321.25 | PE60.1x | E28.8% | n/a | Software | ||
DIGN | SEK 0.87 | -11.7% | -55.7% | SEK 70.1m | SEK 5.50 | PS0.8x | E118.7% | n/a | Healthcare | ||
SPAGO | SEK 0.18 | 4.0% | -34.3% | SEK 64.1m | SEK 0.80 | PS9.2x | E119.8% | n/a | Pharmaceuticals & Biotech | ||
KLAR | SEK 0.30 | -13.1% | -40.2% | SEK 43.3m | SEK 0.70 | PB3.4x | E89.7% | n/a | Pharmaceuticals & Biotech | ||
BONEX | SEK 382.00 | 8.0% | 108.7% | SEK 25.1b | SEK 402.33 | PE277.5x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
SKOLON | SEK 28.00 | -7.3% | 10.7% | SEK 743.2m | SEK 37.50 | PS5x | E135.5% | 2.0% | Software | ||
MIPS | SEK 460.60 | -1.5% | 30.3% | SEK 12.2b | SEK 617.00 | PE117.3x | E48.7% | 1.3% | Consumer Durables | ||
TRUE B | SEK 50.25 | -5.5% | 45.6% | SEK 17.2b | SEK 63.17 | PE35.2x | E23.6% | 0.8% | Software | ||
CTT | SEK 273.00 | -1.4% | 20.3% | SEK 3.4b | n/a | PE38.5x | E33.3% | 2.0% | Capital Goods | ||
EQL | SEK 79.80 | -4.3% | 140.4% | SEK 2.3b | SEK 65.00 | PE74.4x | E53.3% | n/a | Healthcare | ||
XBRANE | SEK 0.16 | -6.4% | -98.5% | SEK 238.6m | SEK 0.45 | PS1.2x | E130.2% | n/a | Pharmaceuticals & Biotech | ||
BIOA B | SEK 212.80 | 23.9% | -21.2% | SEK 18.8b | SEK 322.00 | PS112.5x | E62.5% | 0% | Pharmaceuticals & Biotech | ||
EGTX | SEK 6.59 | 1.1% | 17.3% | SEK 2.4b | SEK 11.50 | PS34.9x | E97.3% | n/a | Pharmaceuticals & Biotech | ||
PAX | SEK 65.00 | 3.5% | 85.7% | SEK 1.2b | SEK 80.00 | PE47x | E60.8% | n/a | Healthcare | ||
SECT B | SEK 273.20 | -0.05% | 55.5% | SEK 52.6b | SEK 285.00 | PE136.9x | E28.5% | 0.4% | Healthcare |